文献速递胃肠外科围术期管理与 ERAS

减重手术与食管癌及胃癌风险的关系

Risk of Esophageal and Gastric Cancer After Bariatric Surgery.
PubMed 文献 · JAMA Surg · 2023-01-01

IMPORTANCE: Bariatric surgery has been associated with a reduced risk of cancer in individuals with obesity. The association of bariatric surgery with esophageal and gastric cancer is still controversial, however.…

要点

  • 减重手术与食管癌及胃癌发病风险降低相关(HR 0.76)。
  • 减重手术组总体住院死亡率显著低于未手术组(HR 0.60)。
  • 严重肥胖患者行减重手术未增加食管胃癌风险。

核心结论

  • 在严重肥胖成人中,减重手术与食管癌及胃癌发病率显著降低相关,且总体住院死亡率显著降低。

研究设计与样本

  • 全国性队列研究,数据来自法国全国出院数据库2010年1月1日至2017年12月31日,纳入年龄≥18岁的严重肥胖成人。

主要发现

  • 共337例发生食管胃癌,手术组83例,对照组254例。

关键数值与推荐

  • 匹配后两组年龄、性别和合并症可比(标准化均数差0.05,SD 0.11),体重指数存在一定差异。
  • 对照组平均随访5.62(2.20)年,手术组平均随访6.06(2.31)年。

临床怎么用

  • 对于严重肥胖患者,减重手术可作为治疗选择,而不必担心增加食管癌及胃癌风险。
  • 减重手术可能同时降低食管胃癌发病率和总体住院死亡率,应在获益评估中予以考虑。

局限性

  • 研究为观察性队列设计,尽管采用倾向性评分匹配,仍可能存在残余混杂。
  • 体重指数在匹配后仍存在一定差异,可能影响结果解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Bariatric surgery has been associated with a reduced risk of cancer in individuals with obesity. The association of bariatric surgery with esophageal and gastric cancer is still controversial, however. OBJECTIVE: To compare the incidence of esophageal and gastric cancer between patients with obesity who underwent bariatric surgery and those who did not (control group). DESIGN, SETTING, AND PARTICIPANTS: This cohort study obtained data from a national discharge database, including all surgical centers, in France from January 1, 2010, to December 31, 2017. Participants included adults (aged ≥18 years) with severe obesity who underwent bariatric surgery (surgical group) or who did not (control group). Baseline characteristics were balanced between groups using nearest neighbor propensity score matching with a 1:2 ratio. The study was conducted from March 1, 2020, to June 30, 2021. EXPOSURES: Bariatric surgery (adjustable gastric banding, gastric bypass, and sleeve gastrectomy) vs no surgery. MAIN OUTCOMES AND MEASURES: The main outcome was incidence of esophageal and gastric cancer. A secondary outcome was overall in-hospital mortality. RESULTS: A total of 303 709 patients who underwent bariatric surgery (245 819 females [80.9%]; mean [SD] age, 40.2 [11.9] years) were matched 1:2 with 605 140 patients who did not receive surgery (500 929 females [82.8%]; mean [SD] age, 40.4 [12.5] years). After matching, the 2 groups of patients were comparable in terms of age, sex, and comorbidities (standardized mean difference [SD], 0.05 [0.11]), with some differences in body mass index. The mean follow-up time was 5.62 (2.20) years in the control group and 6.06 (2.31) years in the surgical group. A total of 337 patients had esophagogastric cancer: 83 in the surgical group and 254 in the control group. The incidence rates were 6.9 per 100 000 population per year for the control group and 4.9 per 100 000 population per year for the surgical group, resulting in an incidence rate ratio of 1.42 (95% CI, 1.11-1.82; P = .005). The hazard ratio (HR) of cancer incidence was significantly in favor of the surgical group (HR, 0.76; 95% CI, 0.59-0.98; P = .03). Overall mortality was significantly lower in the surgical group (HR, 0.60; 95% CI, 0.56-0.64; P < .001). CONCLUSIONS AND RELEVANCE: In this large, nationwide cohort of patients with severe obesity, bariatric surgery was associated with a significant reduction of esophageal and gastric cancer incidence and overall in-hospital mortality, which suggests that bariatric surgery can be performed as treatment for severe obesity without increasing the risk of esophageal and gastric cancer.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Lazzati A, Poghosyan T, Touati M, et al. Risk of Esophageal and Gastric Cancer After Bariatric Surgery. JAMA Surg. 2023. PMID: 36630108. doi:10.1001/jamasurg.2022.6998

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。